A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Emma Kotisalmi, Auli Hakulinen, Mika Mäkelä, Sanna Toppila-Salmi & Paula Kauppi Research-Open Access Asthma Research and Practice volume 6, Article number: 2 (2020) Abstract Background Anti-IgE (omalizumab) and anti-IL5/IL5R (reslizumab, mepolizumab and benralizumab) treatments are available for severe allergic…